Impact of National Economy and Policies on End-Stage Kidney Care in South Asia and Southeast Asia.

IF 1.7 Q3 UROLOGY & NEPHROLOGY International Journal of Nephrology Pub Date : 2021-05-06 eCollection Date: 2021-01-01 DOI:10.1155/2021/6665901
Suceena Alexander, Sanjiv Jasuja, Maurizio Gallieni, Manisha Sahay, Devender S Rana, Vivekanand Jha, Shalini Verma, Raja Ramachandran, Vinant Bhargava, Gaurav Sagar, Anupam Bahl, Mamun Mostafi, Jayakrishnan K Pisharam, Sydney C W Tang, Chakko Jacob, Atma Gunawan, Goh B Leong, Khin T Thwin, Rajendra K Agrawal, Kriengsak Vareesangthip, Roberto Tanchanco, Lina H L Choong, Chula Herath, Chih C Lin, Nguyen T Cuong, Ha P Haian, Syed F Akhtar, Ali Alsahow, Mohan M Rajapurkar, Vijay Kher, Hemant Mehta, Anil K Bhalla, Umesh B Khanna, Deepak S Ray, Sonika Puri, Himanshu Jain, Aida Lydia, Tushar Vachharajani
{"title":"Impact of National Economy and Policies on End-Stage Kidney Care in South Asia and Southeast Asia.","authors":"Suceena Alexander,&nbsp;Sanjiv Jasuja,&nbsp;Maurizio Gallieni,&nbsp;Manisha Sahay,&nbsp;Devender S Rana,&nbsp;Vivekanand Jha,&nbsp;Shalini Verma,&nbsp;Raja Ramachandran,&nbsp;Vinant Bhargava,&nbsp;Gaurav Sagar,&nbsp;Anupam Bahl,&nbsp;Mamun Mostafi,&nbsp;Jayakrishnan K Pisharam,&nbsp;Sydney C W Tang,&nbsp;Chakko Jacob,&nbsp;Atma Gunawan,&nbsp;Goh B Leong,&nbsp;Khin T Thwin,&nbsp;Rajendra K Agrawal,&nbsp;Kriengsak Vareesangthip,&nbsp;Roberto Tanchanco,&nbsp;Lina H L Choong,&nbsp;Chula Herath,&nbsp;Chih C Lin,&nbsp;Nguyen T Cuong,&nbsp;Ha P Haian,&nbsp;Syed F Akhtar,&nbsp;Ali Alsahow,&nbsp;Mohan M Rajapurkar,&nbsp;Vijay Kher,&nbsp;Hemant Mehta,&nbsp;Anil K Bhalla,&nbsp;Umesh B Khanna,&nbsp;Deepak S Ray,&nbsp;Sonika Puri,&nbsp;Himanshu Jain,&nbsp;Aida Lydia,&nbsp;Tushar Vachharajani","doi":"10.1155/2021/6665901","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The association between economic status and kidney disease is incompletely explored even in countries with higher economy (HE); the situation is complex in lower economies (LE) of South Asia and Southeast Asia (SA and SEA).</p><p><strong>Methods: </strong>Fifteen countries of SA and SEA categorized as HE and LE, represented by the representatives of the national nephrology societies, participated in this questionnaire and interview-based assessment of the impact of economic status on renal care.</p><p><strong>Results: </strong>Average incidence and prevalence of end-stage kidney disease (ESKD) per million population (pmp) are 1.8 times and 3.3 times higher in HE. Hemodialysis is the main renal replacement therapy (RRT) (HE-68%, LE-63%). Funding of dialysis in HE is mainly by state (65%) or insurance bodies (30%); out of pocket expenses (OOPE) are high in LE (41%). Highest cost for hemodialysis is in Brunei and Singapore, and lowest in Myanmar and Nepal. Median number of dialysis machines/1000 ESKD population is 110 in HE and 53 in LE. Average number of machines/dialysis units in HE is 2.7 times higher than LE. The HE countries have 9 times more dialysis centers pmp (median HE-17, LE-02) and 16 times more nephrologist density (median HE-14.8 ppm, LE-0.94 ppm). Dialysis sessions >2/week is frequently followed in HE (84%) and <2/week in LE (64%). \"On-demand\" hemodialysis (<2 sessions/week) is prevalent in LE. Hemodialysis dropout rates at one year are lower in HE (12.3%; LE 53.4%), death being the major cause (HE-93.6%; LE-43.8%); renal transplants constitute 4% (Brunei) to 39% (Hong Kong) of the RRT in HE. ESKD burden is expected to increase >10% in all the HE countries except Taiwan, 10%-20% in the majority of LE countries.</p><p><strong>Conclusion: </strong>Economic disparity in SA and SEA is reflected by poor dialysis infrastructure and penetration, inadequate manpower, higher OOPE, higher dialysis dropout rates, and lesser renal transplantations in LE countries. Utility of RRT can be improved by state funding and better insurance coverage.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2021 ","pages":"6665901"},"PeriodicalIF":1.7000,"publicationDate":"2021-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118744/pdf/","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2021/6665901","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 4

Abstract

Background: The association between economic status and kidney disease is incompletely explored even in countries with higher economy (HE); the situation is complex in lower economies (LE) of South Asia and Southeast Asia (SA and SEA).

Methods: Fifteen countries of SA and SEA categorized as HE and LE, represented by the representatives of the national nephrology societies, participated in this questionnaire and interview-based assessment of the impact of economic status on renal care.

Results: Average incidence and prevalence of end-stage kidney disease (ESKD) per million population (pmp) are 1.8 times and 3.3 times higher in HE. Hemodialysis is the main renal replacement therapy (RRT) (HE-68%, LE-63%). Funding of dialysis in HE is mainly by state (65%) or insurance bodies (30%); out of pocket expenses (OOPE) are high in LE (41%). Highest cost for hemodialysis is in Brunei and Singapore, and lowest in Myanmar and Nepal. Median number of dialysis machines/1000 ESKD population is 110 in HE and 53 in LE. Average number of machines/dialysis units in HE is 2.7 times higher than LE. The HE countries have 9 times more dialysis centers pmp (median HE-17, LE-02) and 16 times more nephrologist density (median HE-14.8 ppm, LE-0.94 ppm). Dialysis sessions >2/week is frequently followed in HE (84%) and <2/week in LE (64%). "On-demand" hemodialysis (<2 sessions/week) is prevalent in LE. Hemodialysis dropout rates at one year are lower in HE (12.3%; LE 53.4%), death being the major cause (HE-93.6%; LE-43.8%); renal transplants constitute 4% (Brunei) to 39% (Hong Kong) of the RRT in HE. ESKD burden is expected to increase >10% in all the HE countries except Taiwan, 10%-20% in the majority of LE countries.

Conclusion: Economic disparity in SA and SEA is reflected by poor dialysis infrastructure and penetration, inadequate manpower, higher OOPE, higher dialysis dropout rates, and lesser renal transplantations in LE countries. Utility of RRT can be improved by state funding and better insurance coverage.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
南亚和东南亚国家经济和政策对终末期肾脏护理的影响。
背景:即使在经济水平较高的国家(HE),经济状况与肾脏疾病之间的关系也没有得到充分的探讨;在南亚和东南亚(SA和SEA)的较低经济体(LE),情况很复杂。方法:以国家肾脏病学会代表为代表,以问卷和访谈为基础,对经济状况对肾脏护理的影响进行了评估。结果:终末期肾病(ESKD)每百万人口(pmp)的平均发病率和患病率分别是HE组的1.8倍和3.3倍。血液透析是主要的肾替代疗法(RRT) (HE-68%, LE-63%)。高等教育机构的透析资金主要由国家(65%)或保险机构(30%)提供;LE的自付费用(OOPE)很高(41%)。血液透析费用最高的是文莱和新加坡,最低的是缅甸和尼泊尔。透析机的中位数/1000 ESKD人群中,HE为110台,LE为53台。HE组平均机器/透析单位数是LE组的2.7倍。HE国家的透析中心pmp(中位数HE-17, LE-02)高出9倍,肾病专家密度高出16倍(中位数HE-14.8 ppm, LE-0.94 ppm)。透析次数>2次/周在高输血率(84%)和10%在除台湾以外的所有高输血率国家,10%-20%在大多数低输血率国家。结论:在LE国家,SA和SEA的经济差异体现在透析基础设施和渗透率差、人力不足、OOPE较高、透析辍学率较高、肾移植较少。RRT的效用可以通过国家资助和更好的保险覆盖面来提高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Nephrology
International Journal of Nephrology UROLOGY & NEPHROLOGY-
CiteScore
3.40
自引率
4.80%
发文量
44
审稿时长
17 weeks
期刊介绍: International Journal of Nephrology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies focusing on the prevention, diagnosis, and management of kidney diseases and associated disorders. The journal welcomes submissions related to cell biology, developmental biology, genetics, immunology, pathology, pathophysiology of renal disease and progression, clinical nephrology, dialysis, and transplantation.
期刊最新文献
Chronic Kidney Disease: Decreasing Serum Klotho Levels Predict Adverse Renal and Vascular Outcomes. Urinary Nephrin: A Potential Biomarker of Early Glomerular Injury in a Cohort of Pregnant Women Attending Routine Antenatal Care Services. Peritoneal Dialysis of Three-Cuff Catheter Experience in Qassim Province, Saudi Arabia. The Protective Activity of Withania somnifera Against Mercuric Chloride (HgCl2)-Induced Renal Toxicity in Male Rats. Key Performance Indicators of Secondary Health Care in Chronic Kidney Disease: Experience in Public and Private Services in the State of São Paulo, Brazil.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1